Blake Borgeson
12 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 12 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $155K | Nov 3SEC filing | |
| Sell(10b5-1 plan) | $242K | Oct 6SEC filing | |
| Sell(10b5-1 plan) | $100K | Sep 1SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Blake Borgeson's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 12 |
Alerts for Blake Borgeson
Use this page
How to cite
Breakaway, Blake Borgeson: Director at Recursion Pharmaceuticals (RXRX), Nov 4, 2026, getbreakaway.com/insiders/blake-borgeson
Journalists: email support@getbreakaway.com for the data behind this page.